In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and Prevention reported.
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
A recent study published in JAMA Health Forum that examines CARES Act Provider Relief Funds allocated to health care providers misses the point of those payments and makes arbitrary choices about which payments to include, writes Ashley Thompson, AHA senior vice president for public policy analysis and development, in a new AHA blog post.
by Ashley Thompson - AHA Senior Vice President, Public Policy Analysis and Development
A recent study published in JAMA Health Forum (“Association Between COVID-19 Relief Funds and Hospital Characteristics in the U.S.”) that examines CARES Act Provider Relief Funds allocated to health care providers misses the point of those payments and makes arbitrary choices about which payments to include.
The National Institutes of Health will use $70 million from the American Rescue Plan Act for a program to speed development of accurate and reliable over-the-counter tests for COVID-19, the Department of Health and Human Services announced.
Oct. 26 is the deadline for health care providers to apply to the Health Resources and Services Administration for a portion of $25.5 billion in COVID-19 relief funds.
Increased health care use and intensity of services have been the key drivers of health care spending growth as the U.S. population continues to age, with hospital price growth averaging just 2% annually from 2010 to the start of the COVID-19 pandemic, according to a report released today by the AHA.
Hospitals and health systems have worked hard to address workforce challenges as the COVID-19 surges continue, but are running out of options and need Congress’ help, writes Robyn Begley, AHA chief nursing officer and CEO of the American Organization for Nursing Leadership, in MedPage Today.
The AHA released a new COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
Treatment with subcutaneous interferon beta-1a plus remdesivir was not superior to treatment with remdesivir alone in a clinical trial that enrolled 969 hospitalized adults with COVID-19 pneumonia in the United States, Japan, Mexico, Singapore and South Korea, the National Institutes of Health reported.
The Health Resources and Services Administration Oct. 21 will host the last in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds.
by Rod Hochman, M.D.
Working in health care delivery can be stressful and tiring under normal circumstances. And the COVID-19 pandemic has exerted incredible pressures on the emotional and physical well-being of our health care professionals.
The Department of Health and Human Services has renewed the COVID-19 public health emergency declaration for another 90 days effective Oct. 18.
The National Institutes of Health awarded a total of $78 million in funding to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, with the goal of bringing to market as soon as this year new home and point-of-care tests that can detect multiple respiratory infections.
The AHA released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
A new study released by the National Academies of Sciences, Engineering and Medicine offers advice for communicating with parents about their children’s COVID-19 vaccination, along with strategies for building public confidence in the vaccines
Food and Drug Administration staff provided their analysis of Johnson & Johnson’s COVID-19 booster application, indicating that a second dose provides substantially more protection against SAR-CoV-2 than the initial shot.
The Centers for Disease Control and Prevention has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population.
The Health Resources and Services Administration Oct. 13 will host the third in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds
Merck announced its submission for a Food and Drug Administration emergency use authorization of its investigational oral antiviral COVID-19 medicine.
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued details on several key changes related to the REGEN-COV COVID-19 monoclonal antibody therapy.